AIM: This review discusses the most common used antifungal agents in the treatment of invasive fungal infections. In addition, guidelines for the treatment of invasive aspergillosis, as used in the Ghent University Hospital, are described. Moreover, the importance of determining the effectiveness of antifungal therapy as well as the potential role of the hospital pharmacist in the management of this infection is highlighted. METHODS: A review of the English-language literature was conducted using the MEDLINE database and scientific websites. Search terms including antimycotics, antifungal therapy and invasive aspergillosis were used to refine the search, and preference was given to studies published after 1992. This was completed with recent treatment guidelines. RESULTS: An overview of the most recent advances in antifungal therapy is described. In addition, a flowchart for treatment of invasive aspergillosis (proven, probable or possible) has been developed. CONCLUSION: Invasive fungal infections will remain a frequent and important complication of modern medicine. Considering the clinical and financial outcome of invasive fungal infections, the role of the hospital pharmacist can be a paramount to the treatment.
AIM: This review discusses the most common used antifungal agents in the treatment of invasive fungal infections. In addition, guidelines for the treatment of invasive aspergillosis, as used in the Ghent University Hospital, are described. Moreover, the importance of determining the effectiveness of antifungal therapy as well as the potential role of the hospital pharmacist in the management of this infection is highlighted. METHODS: A review of the English-language literature was conducted using the MEDLINE database and scientific websites. Search terms including antimycotics, antifungal therapy and invasive aspergillosis were used to refine the search, and preference was given to studies published after 1992. This was completed with recent treatment guidelines. RESULTS: An overview of the most recent advances in antifungal therapy is described. In addition, a flowchart for treatment of invasive aspergillosis (proven, probable or possible) has been developed. CONCLUSION:Invasive fungal infections will remain a frequent and important complication of modern medicine. Considering the clinical and financial outcome of invasive fungal infections, the role of the hospital pharmacist can be a paramount to the treatment.
Authors: Vera von Gunten; Viviane Amos; Anne-Laure Sidler; Johnny Beney; Nicolas Troillet; Jean-Philippe Reymond Journal: Pharm World Sci Date: 2003-04
Authors: E J Anaissie; D P Kontoyiannis; C Huls; S E Vartivarian; C Karl; R A Prince; J Bosso; G P Bodey Journal: J Infect Dis Date: 1995-08 Impact factor: 5.226
Authors: Susanne Perkhofer; Harald Niederegger; Gerhard Blum; Wolfgang Burgstaller; Maximilian Ledochowski; Manfred P Dierich; Cornelia Lass-Flörl Journal: Int J Antimicrob Agents Date: 2007-02-02 Impact factor: 5.283
Authors: Julian Pardo; Christin Urban; Eva M Galvez; Paul G Ekert; Uwe Müller; June Kwon-Chung; Mario Lobigs; Arno Müllbacher; Reinhard Wallich; Christoph Borner; Markus M Simon Journal: J Cell Biol Date: 2006-08-07 Impact factor: 10.539